Emergency Medicine Doctors in Canton, MI Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Dr. John R Collop, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 N Canton Center Rd, Emergency Medicine Dept, Canton, MI 48187 Phone: 734-454-8002    Fax: 734-454-2733

Dr. Chada Natalie Reddy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 Canton Center Road, Emergency Medicine Department, Canton, MI 48187 Phone: 734-454-8002    Fax: 734-454-2733

Dr. Ifeoma N Kamalu, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 N Canton Center Rd, Canton, MI 48187 Phone: 734-454-8002    Fax: 734-454-2733

Asad Mahmoud Tarsin, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 N Canton Center Rd, Canton, MI 48187 Phone: 734-454-8001

Dr. David Weaver, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 7300 N Canton Center Rd, Emergency Medicine Department, Canton, MI 48187 Phone: 734-454-8002    Fax: 734-454-2733

Dr. Tracey Lynne Venning, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 S Canton Center Rd, Canton, MI 48188 Phone: 734-844-8743    Fax: 734-844-8744

Martha J Shadel, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 Canton Center Dr, (emergency Dept), Canton, MI 48187 Phone: 734-454-8002    Fax: 734-454-8161

Dr. John Alex Jansen Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7300 N Canton Center Rd, Emergency Medicine Department, Canton, MI 48187 Phone: 734-454-8002    Fax: 866-250-6385

News Archive

Mayo Clinic provides new strategy for designing better treatments for juvenile dermatomyositis

Mayo Clinic researchers, working with colleagues at the University of Minnesota and University of Pittsburgh, are the first to describe a new role for a specialized cell of the immune system in children suffering from a rare muscle-damaging disease known as juvenile dermatomyositis (JDM).

Smartphone app can detect worsening symptoms during cancer treatments

Cancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm that detects worsening symptoms based on objective changes in patient behavior, according to a new study from the University of Pittsburgh and UPMC Hillman Cancer Center.

Adoption of new technologies can transform healthcare system

According to Julie Klapstein, CEO of leading health information network Availity, LLC, "Technology adoption by health care providers will be a key determinant in the speed with which our nation's health care system is transformed, and the speed at which patients and providers benefit from better clinical outcomes."

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.

Read more Medical News

› Verified 6 days ago